The parasitologist Maggie Fisher is coordinating a survey across the UK on behalf of Bayer Healthcare, to test the efficacy of their flea treatment 'Advantage'.
She is looking to enlist some new practices to help her collect field strains of flea eggs in return for payment of £40 per sample.
If you are regularly seeing flea ridden cats or dogs and could help collect one or more samples of flea eggs by the end of November then please contact Jo Goodman on 01594 530809 or email her at Jo@ridgewayresearch.co.uk.
According to the charity, FIP, which is one of a number of chronic viral infections of cats that resemble those in people, is estimated to kill up to 1.4% of cats around the world.
The infectious agent is a mutant coronavirus (FIPV) that is notoriously difficult to control: the parent enteric coronavirus is present in virtually all catteries and shelters and is shed by 60% or more of pet cats from multi-cat households,1 and vaccines are ineffective.
Among the most promising treatments against emerging viruses in humans is 'GS-5734', one of the small-molecule antivirals targeting specific proteins involved in RNA virus replication.
In studies, it has proven effective in preventing Ebola in rhesus monkeys and inhibiting coronaviruses both in tissue culture and in mouse infection models.
It was these findings that brought it to the attention of a team of veterinary researchers in the USA, led by Professor Niels Pedersen of the University of California, Davis.
Their own initial studies involving experimental FIP showed that the less chemically complex 'GS-441524', the parent nucleoside of GS-5734, was highly effective, opening the way for a field trial in cats with naturally occurring FIP, the results of which are published in this week's JFMS2.
Thirty-one cats, ranging in age from 3–73 months, were enrolled in the study, and 26 completed the planned 12 weeks or more of treatment; the remainder died or were euthanised due to their severe disease.
For these 26 cats, the clinical response was dramatic: fever usually resolved within 12–36 h, concurrent with a marked improvement in appetite, activity levels and weight gain.
In cats with the more common effusive or ‘wet’ form of FIP, abdominal effusions rapidly disappeared, starting at around 10–14 days after commencing treatment.
Encouragingly, and somewhat unexpectedly, cats with non-effusive (‘dry’) FIP and older cats responded as well to GS-441524 treatment as did cats with effusive FIP and young cats. The safety profile of GS-441524 was likewise impressive.
Currently, 24 of the 26 cats remain healthy, with one having succumbed to FIP disease and one to unrelated heart disease. Eighteen of these cats underwent just one round of treatment; the remaining eight suffered disease relapses, but these were successfully treated with a further (in two cases, a third) round of treatment at a higher dose.
Previously the prospects for cats with FIP were bleak. In a review paper on FIP published in JFMS a decade ago, Professor Pedersen stated: "no treatment has proven effective in curing cats of FIP, in spite of the claims. Cats that develop FIP inevitably die of their disease in days, weeks or months."1
Now, as he approaches the end of his professional career, Professor Pedersen is considerably more optimistic: "FIP has been my fascination for the past 50 years and I am fortunate to have reached a final stage in my career having identified safe and effective antiviral drugs. We now know that small molecules targeting specific steps in RNA virus replication are capable of safely curing various forms of FIP."
However, he cautioned: "It must be emphasised that the field trial we report was for proof-of-concept and the results cannot be immediately translated into commercially available products.
"Unfortunately, the real hope provided by these initial trials has increased, and not decreased, the desperation of owners to seek out these new drugs on the black market. As eventful as these discoveries may be, there is still much more about FIP to discover.
"I would like to thank all of the people, organizations and owners who have assisted in my research over this half century and leave remaining questions and associated discoveries for my fellow FIP researchers."
Reference
Photo: Bubba, one of the study cats, in recovery. Courtesy Adel Gastle
Genitrix has launched Libromide, the first licensed formulation of potassium bromide for the treatment of canine epilepsy, following what the company believes to be the largest ever trial of dogs suffering from epilepsy.
Genitrix says the availability, for the first time, of a licensed formulation of potassium bromide should give veterinary surgeons and pet owners the reassurance that the rigorous authorisation process provides. It ensures, for instance, that the product has been developed especially for dogs and that it is manufactured in accordance with EU regulations. It also ensures that the product has been extensively and independently trialled, proven to be efficacious without adverse reactions, and that the necessary pharmacovigilance is in place to support it.
The company also says that the availability of a licensed product paves the way for more comprehensive information to be provided to veterinary surgeons on the use of potassium bromide in treating seizures. The Veterinary Medicines Directorate (VMD) imposes restrictions on educational materials supplied by manufacturers of unlicensed products, an approach which has created a 'knowledge gap' among many veterinary surgeons in general practice, according to some canine epilepsy experts.
Libromide tablets are intended for use in epileptic dogs which have already commenced therapy with Phenobarbital. Phenobarbital acts to increase the effects of the GABA inhibitory neurotransmitter in the central nervous system. Potassium bromide is synergistic with Phenobarbital and raises the seizure threshold level in epileptic dogs.
Libromide is classified as POM-V and will be available in 325 mg tablets in packs of 100 and 500 tablets.
Rodolfo Cappello DVM PhD DipECVN MRCVS, RCVS and European Specialist in Neurology and Neurosurgery, Head of Neurology Services at North Downs Specialist Referrals, Surrey, said: "I've been successfully using potassium bromide for the treatment of epilepsy in dogs for over 15 years. The main problem has been that it's not been licensed as a medicine. With the launch of Libromide, potassium bromide finally achieves the status of an approved pharmaceutical. We will now be able to monitor quality, efficacy and side effects which will enable us to offer a more professional approach to the treatment of seizures."
Howard Wilder, founder and managing director of Genitrix, added: "Canine epilepsy is an all too common disease with estimates suggesting it affects four in every hundred dogs in the UK. It's also an illness which is not well enough understood with the lack of up to date information available to veterinary surgeons being a contributing factor.
We felt there was an opportunity to bring a licensed product to market and have invested hundreds of thousands of pounds in the process of development and trialling Libromide. We're delighted to make it available to veterinary professionals and hope its launch will be the first step in improving treatment approaches for this distressing disease."
The RSPCA has published the results of a survey which found that teachers in the UK are strongly in support of teaching animal welfare in the classroom, with 93% of respondents stating they would teach animal welfare in the classroom if they had the time.
95% also said that they believe that teaching children about animal welfare would help make them more compassionate and socially aware.
According to the survey of almost 800 teachers across England and Wales, 83% felt animal welfare should be part of the national curriculum. However, some had concerns about how it would be integrated into existing frameworks, and whether it would mean more demands on already overworked teachers.
RSPCA formal education manager Claire Morris said: "We felt it is easy to sit on the sidelines and state that animal welfare should be part of the curriculum, but it is far more practical and helpful to show that it can be done."
To address these concerns, the RSPCA says it created over 90 free lesson plans for teachers, which are linked to the English and Welsh Curricula. Many of the RSPCA's lesson plans overlap in subject areas including Science, Citizenship, Literacy and Numeracy, as well as provide springboards for assemblies and student councils.
Claire added: "We urge the government to consider integrating animal welfare into our children's education as a matter of urgency - as skills such as empathy, compassion and social consciousness have value as a child goes through the education system as well as when they enter adulthood and the world of work."
The RSPCA says this is particularly important because only 70% of respondents knew what the five animal welfare needs - which are central to the Animal Welfare Act - are.
As well as looking at the ethical side of animal welfare, 92% of teachers also expressed a strong preference for lessons specifically on animals' role in food and clothing production. It was felt that with young people better connected than ever before, they have an increasing awareness of social issues and expect higher ethical standards from companies.
The National Office of Animal Health has launched http://www.pethealthinfo.org.uk/, a new website that bills itself as: "A 'one stop shop' featuring a wealth of animal health information and advice to help owners and potential owners to make decisions about their pets' healthcare."
I must say, full marks to NOAH and the web designers 9xb for a really polished website that presents information in a very easy-to-navigate format. First class job.
In general, the site content seems very good too. There's help for owners deciding what pet to buy, health guides for various common conditions for each species, first aid advice, and much more.
Personally, I think it would have been a nice tweak to offer something a tad more interactive in the section about picking a pet - something that actually made suggestions depending on your answers to the questions the site poses.
I also wonder how useful the Vet FAQs are likely to be. There are so many possible questions a pet owner might have, that a slightly random list seems to me to be of limited use.
But these are small points in the grand scheme of things. Overall, an excellent production, and one you may want to link your practice website to.
The RCVS and BVA have expressed their concern about a BBC Newsline report last week of suspected badger baiting in Northern Ireland, which also alleged that veterinary surgeons might be complicit in this illegal activity by not reporting cases of suspiciously injured animals to the relevant authorities.
Bert Allison MRCVS, President of the North of Ireland Veterinary Association, said: "Our Association, and veterinary surgeons across Northern Ireland and Great Britain, are sickened and appalled by these activities. We are grateful to the BBC for highlighting the problem and bringing it to the attention of the public.
"Veterinary surgeons work under a professional code of conduct to uphold animal health and welfare and care deeply about the animals under their care. The claim by USPCA that veterinary surgeons are deliberately failing to report incidents is therefore shocking.
"However, if there is evidence that this has happened the USPCA must provide all relevant information to the Royal College of Veterinary Surgeons which is the statutory regulator of the veterinary profession.
"Under our professional code all veterinary surgeons must provide treatment to alleviate the suffering of an animal presented to them however the gangs abusing these animals may be obtaining veterinary care by deception. We are contacting our members urgently to offer support and remind them how to report suspected incidents safely and within the law."
The RCVS says it has yet to be presented with any evidence to support the claims, but will investigate any genuine complaint supported by first-hand evidence.
The College is also reminding veterinary surgeons about its guidance concerning breaching client confidentiality where a veterinary surgeon believes that animal welfare or the public interest may be compromised.
If there is suspicion of animal abuse, as a result of examining an animal, a veterinary surgeon should consider whether the circumstances are sufficiently serious to justify breaching the usual obligations of client confidentiality.
In cases where discussing these concerns with the client would not be appropriate, or where the client's reaction increases rather than allays these concerns, the veterinary surgeon should contact the relevant authorities, for example the RSPCA, SSPCA or USPCA, to report alleged cruelty to an animal.
Such action should only be taken when the veterinary surgeon considers on reasonable grounds that the public interest in protecting an animal overrides the professional obligation to maintain client confidentiality.
A veterinary surgeon may contact the RCVS for advice before any confidential information is divulged (020 7202 0789 / profcon@rcvs.org.uk).
Hill's Pet Nutrition has reported some early results from its '60 Tonnes in 6 Months' pet weight loss campaign, which started 2 months ago.
The company says that although there is only preliminary data available from 33 practices, it's clear that the campaign is working, with each practice involved reporting on average over 10 Kg weight loss from their patients. However, many practices are holding on to send in results until their patients have reached their final targets, so more data is expected.
Hill's says that some practices have had great success using its PR kit, generating positive coverage in local newspapers. Sara Locke, Associate Customer Marketing Manager is reminding practices that January is the traditional time for 'dieting fever' to hit the headlines after the indulgencies of the festive season. She said: "If you have one of our PR kits, don't forget to send out your pro forma press release - it's not a big task to customise it with your practice details and you could find yourself making a big splash locally at a time when we know interest will be heightened."
As part of the campaign, Hill's has also produced a series of nurse webinars, the last of which was on exercise and rehabilitation programmes for overweight pets and contains tips on how to develop a personalised exercise programme that fits with the owner's lifestyle and reflects the pet's capabilities and level of mobility. The webinar can be viewed here: https://hillsvet.webex.com/hillsvet/lsr.php?AT=pb&SP=EC&rID=13881732&rKey=E1182C100CB53476
Further information is available from local Hill's Territory Managers or by calling Hill's on 0800 242438 or in ROI 1 800 626002.
In part one of the article, Professor Ernst made the case that homeopathy has no place in veterinary (or human) evidence-based medicine.
In part two, he considered a number of other types of so-called alternative medicine (or 'SCAM', as he called it in the self-published version) for animals, including acupuncture, chiropractic, energy healing and dietary supplements, concluding that most such SCAMS are unproven and that 'arguably it is unethical to use unproven medicines in routine veterinary care'.
Now is it just me, or does anyone else find the Veterinary Record position rather worrying?
Surely a scientific journal should concern itself with one thing and one thing only: the search for scientific truth? Surely, therefore, the question of how many veterinary surgeons use a therapy is completely irrelevant. Or am I being idealistic?
I also struggle with the idea that Professor Ernst could be told to go away and provide more balance.
How exactly is anyone supposed to balance the argument that there's no evidence that a therapy works? The only counter or balancing argument would be that it does. Catch 22.
Most learned people know that homeopathy is not just a little bit implausible, but completely off-the-scale-bonkers-in-a-'world-is-not-flat-sort-of-a-way', along with energy healing and chiropractic.
But acupuncture? I'll bet Professor Ernst's words will make for uncomfortable reading for some. That's precisely what seems to have made the Veterinary Record balk. But surely that's the whole point of science. To cause us all to challenge our beliefs, even (or especially) if it makes us uncomfortable.
You can read Professor Ernst's blog at: https://edzardernst.com/
The results, in order of number of votes, are:
Elected: Susan Paterson – 3,976 votes
Elected: Mandisa Greene – 3,819 votes
Elected: Neil Smith – 3,544 votes
John Innes – 3,502 votes
David Catlow – 3,310 votes
Matthew Plumtree – 2,677 votes
Iain Richards – 2,635 votes
Karlien Heyrman – 2,487 votes
John Davies – 580 votes
Thomas Lonsdale – 542 votes
Due to the fact that a Legislative Reform Order (LRO) that amends the College’s governance has completed its passage through the House of Commons and House of Lords and is expected to be signed off by the relevant Minister to bring it into law, only the first three candidates are expected to take up their posts on Council at RCVS Day on 13 July 2018.
Eleanor Ferguson, RCVS Registrar and Returning Officer for the election, said: "I would like to thank all the candidates who stood for Council this year and would like to, in particular, congratulate Susan, Mandisa and Neil for being re-elected to RCVS Council.
"The LRO that is likely to be signed off in due course will reconstitute the makeup of Council – with greater lay and veterinary nursing input – and will also reduce the overall size of Council, including the number of elected members. Because of this only the first three – as opposed to the first six under previous rules – candidates are likely to be taking up a four-year term at RCVS Day 2018. Our commiserations go out to all the unsuccessful candidates, especially in this unusual transitional year, and we thank them for their participation in this year’s election."
The results of the election will be formally declared at this year’s RCVS Day – the College’s Annual General Meeting and awards ceremony – which takes place at the Royal Institute of British Architects on Friday 13 July 2018.
Janssen Animal Health has launched Domosedan Gel, an oromucosal gel for the sedation of horses.
Janssen says Domosedan Gel, which contains 7.6 mg/ml (40mcg/kg) detomidine, induces sedation and analgesia with the efficacy and recovery comparable to Domosedan injection. Domosedan Gel is administered under the horse's tongue, so it is rapidly absorbed.
The company also says Domesedan Gel can replace physical restraint and improve safety during treatments, diagnostics and transport, and that the gel is ideal for horses that are nervous or needle-shy and when owners need more control during clipping, shoeing, dental treatments and boxing.
Nicki Glen, marketing manager at Janssen Animal Health said: "Domosedan Gel is proven to be both effective and easy-to-administer with 98% of horses accepting the gel and owners finding it easy and convenient to use.
"The gel starts to be absorbed immediately and demonstrates a reliable sedatory effect and high safety margin, making it an ideal solution for sedation and restraint when performing non invasive procedures on horses."
For further information, please contact your Janssen Animal Health territory manager.
Animal training and behaviour experts have joined forces to try and end bad practice by poorly trained individuals.
The Animal Behaviour and Training Council is being launched to regulate the education and training of those working in the animal behaviour modification sector.
The new organisation brings together leaders in the veterinary, welfare, rehoming, animal training and behaviour therapy fields. It aims to set standards for the knowledge and skills required to be a recognised professional.
The agreed standards will be used to assess the competency of practitioners before they are included on the Council's national register of animal trainers and behaviour therapists. The details will be publicly available to help people to find an appropriate expert.
The standards will also help those seeking a career in animal behaviour or further developing the skills of those already practicing the profession.
Council chairman David Montgomery said: "Regulation of this industry sector is long overdue. The formation of the council has been met with widespread enthusiasm and support from professional organisations both in the UK and overseas."
Organisations represented on the Council already include major charities such as RSPCA, Guide Dogs and The Blue Cross, with interest being expressed from organisations in Europe, Australia and Brazil.
Senior lecturer in companion animal behaviour and welfare at Bristol University Dr Rachel Casey said: "There is currently a plethora of groups and individuals providing dog training which makes it difficult for owners to choose the right one to suit the needs of their pet.
"We believe that the ABTC will aim to solve this problem and will be a very important step forward in raising standards in animal training and behaviour."
For more information visit: www.abtcouncil.org.uk
BVA Past President Peter Jones is appearing before an All Party Parliamentary Group (APPG) on Antibiotics today, to update parliamentarians and stakeholders on the efforts the association and the profession are making to tackle the issue. Speaking to the APPG, Peter will say: "We know that the biggest cause of antibiotic resistance in humans is the overuse and misuse of antibiotics in human medicine and this was highlighted in the joint report on resistance from the Department of Health (DoH) and Defra.
"However, we are not complacent about the role of antibiotic use in veterinary medicine and we are one of the leading voices in the campaign for the responsible use of antibiotics in all species.
"We remain committed to the One Health principle and the need for the medical and veterinary professions to work together to tackle antimicrobial resistance. BVA and our specialist divisions are currently working on a plan to deliver the five-year strategy on AMR from the veterinary perspective. The actions being taken have been published along with those of our partners in the RUMA response to the DoH/Defra strategy.
"One of our key aims for the strategy will be to promote the importance of evidence-based responsible use among both vets and their clients. We are already encouraging education on minimising resistance and principles of responsible use through engagement with the veterinary schools and other stakeholders, and through our own continuing professional development (CPD) programme.
"The use of antibiotics in veterinary medicine in Europe in the future may well be different to how we have used them in the past, with certain constraints on certain classes of critically important medicines used in man. We will cooperate in adapting to this new environment but any changes must be based on sound scientific risk analysis and not on misrepresentation of the evidence, or at worse falsification of that evidence."
Another key action for BVA is the updating of BVA's responsible use guidance for the veterinary profession, and BVA's species divisions continue to work on advice tailored to their particular sectors.
BVA is also continuing to call for quicker, cheaper and more accessible accurate sensitivity and pen-side testing for veterinary use, and repeated this call in recent submissions to the Science & Technology Select Committee and the APPG on Eggs, Pigs and Poultry.
BVA has also agreed in principle that antibiotic use should be recorded and reported and will consider how such recording and reporting may be encouraged, how usage may be measured and audited, and how prescribing habits can be assessed. Such measures will help us to monitor trends in resistance development and track the progress we can make in addressing the problem.
Vetoquinol - makers of the NSAID Cimalgex - has announced the launch of its updated website www.CiMyDog.co.uk.
The company says the website has been developed to provide reliable online information about pain in dogs to cater for the increasing needs of pet owners and vets.
The website has two sections. The first is a pet owner focussed, educational tool which takes the visitor on a journey through the process of pain; from spotting the signs of pain all the way through to ways of relieving pain, culminating in the recommendation that the visitor seeks advice from their veterinary practice.
The second section requires registration as it contains more in depth information on the pain process and potential treatment options available, this section is for veterinary professionals only. Also on this section of the website there are many scientific abstracts related to pain and treatment with links to enable the veterinary visitor can view this peer reviewed material.
Robert Simpson, Cimalgex Product Manager said: "The internet is a very powerful tool in terms of increasing education, especially in areas such as canine pain. Unfortunately there can also be a lot of misinformation online and so we felt it was important for Vetoquinol to try and redress the balance by producing www.CiMyDog.co.uk. This can be used as a reliable and up-to-date resource by pet owners and veterinary professionals alike. -
www.CiMyDog.co.uk is a very interactive site which aims to demystify the pain treatment process, ensure pet owners look out for behavioural signs of pain and looks to improve overall canine health with assistance from their veterinary practice. We hope that this will be a valuable resource to which vets can refer their pet owners."
The RCVS has opened a consultation on the future of veterinary specialisation, which includes a proposal that the use of postnominals and titles by veterinary surgeons should be rationalised in order to avoid confusion amongst the public.
The proposals are submitted for comment by the RCVS Specialisation Working Party, which is chaired by former Chief Medical Officer Professor Sir Kenneth Calman.
The Working Party's review was precipitated by a finding that the structure of veterinary specialisation is "confusing and opaque" to both animal owners and the profession (Unlocking Potential - a Report on Veterinary Expertise in Food Animal Production, by Professor Philip Lowe, 2009).
The Working Party has explored the routes to RCVS Recognised Specialist status. It has also looked at the use of 'specialist' more broadly, given the fact that it is not a protected term in the veterinary field, and has considered animal owners' expectations of a 'specialist'.
The Working Party also makes proposals for encouraging more veterinary surgeons to become specialists, given that there are currently only 319 on the RCVS List of Recognised Specialists, out of a UK practising arm of the profession of some 17,400 veterinary surgeons.
The proposals from the Working Party could have far-reaching impact. One suggestion is that all those meeting the criteria for specialist status would also become Fellows of the RCVS (FRCVS) - a status currently only held by those who complete a thesis or exam, or who qualify on the basis of 'meritorious contributions to learning'. There are also proposals that the term 'RCVS Recognised Specialist' be dropped and replaced with the much simpler term 'specialist' or 'veterinary specialist'.
Further proposals include the introduction of a 'middle tier' of veterinary surgeons - potentially to be called 'advanced practitioners' - who would be below full specialist status and subject to periodic revalidation.
There are also recommendations that veterinary surgeons should be obliged to explain referral options to their clients, including the level of expertise of those to whom they are referring cases.
The future of the RCVS subject boards, which currently manage the various Certificate and Diploma examinations, is also considered in the proposals.
The emphasis throughout is on simplification and improvement, according to Professor Sir Kenneth Calman, who said: "New legislation to introduce statutory registration for veterinary specialists would no doubt make things clearer, as it is for doctors and dentists, but, in the meantime, we believe there are a number of actions which the RCVS could take to improve matters."
The consultation paper can be downloaded from www.rcvs.org.uk/consultations, and comments are welcomed from members of the public, veterinary surgeons and veterinary nurses. The closing deadline for comments, which should be sent to RCVS Head of Education, Freda Andrews, on f.andrews@rcvs.org.uk, is Friday 9 December.
Comments received will be considered by the RCVS committees and Council in early 2012.
Bayer Animal Health has launched four short youtube films about parasites, fronted by celebrity veterinary surgeon, Scott Miller.
The press blurb says the films "will provide pet owners with an amazing and educational journey into the world of parasites and highlight the need for the control of these often unwelcome pests", which I would normally translate as: "will provide anyone with too much time on their hands with a rather dull five minute advertisement for our flea treatment".
But no. The big surprise is that in addition to the slick production values, these films actually are rather interesting. I've just watched the first, and learned a bit about the vampire bat. There's some compelling infra-red footage of some of them feeding on a sleeping horse.
Elsewhere in the You Tube clips, Scott discusses other parasites including fleas, ticks and worms, and shows the harm they can inflict if owners don't sufficiently protect their cats and dogs with appropriate treatments. On that score, he urges owners to seek veterinary advice. Scott also discusses the threats posed by the increasing urbanisation of foxes and by exotic diseases that are now being found much further north as a result of climate change.
Matt Frost, UK marketing manager at Bayer Animal Health, says: "The clips, all of which are around four minutes in length, provide an opportunity for pet owners to learn more about parasites in a novel and entertaining way. We hope that viewers will learn more about the inherent dangers some of these creatures pose to pets and the steps that can be taken to protect against them.
The other clips can be viewed online at www.youtube.com/user/parasitesundercover1. You might even like to embed them from youtube into your own practice website.
The British Veterinary Asssociation and British Small Animal Veterinary Association have strongly welcomed moves to tighten up the rules on dog breeding in Wales with the publication of the proposed Animal Welfare (Breeding of Dogs) (Wales) Regulations 2011.
The draft proposals follow a report by an expert Task and Finish Group, including veterinary representatives, which made recommendations for new legislation to tackle the significant problem of puppy farming.
The BVA and BSAVA were both represented on the Task and Finish Group and have welcomed the proposals, which include:
The draft legislation is now out for consultation until 13 January 2011.
Harvey Locke, BVA President, said: "The Welsh Assembly Government should be congratulated for driving forward legislative changes to tackle the abhorrent practice of puppy farming.
"The Task and Finish Group brought together everyone with an interest in dog health and welfare so the Minister should be confident that these proposals will gain widespread support.
"Puppy farming is not only a problem in Wales and it is clear that the rest of the UK is now lagging behind. We will be encouraging England, Scotland and Northern Ireland to follow suit and ensure dog health and welfare is promoted across the country."
Grant Petrie, President of BSAVA, added: "Vets are often faced with the terrible consequences of puppy farms and bad breeders, which can lead to suffering for both the animals and their owners.
"We are delighted that this action is being taken by the Welsh Assembly Government.
"The compulsory microchipping of dogs and puppies on licensed premises is a particularly welcome move but the veterinary profession will continue to campaign for this to be extended to all dogs."
The RCVS has extended its alternative dispute resolution (ADR) trial until October 2015 and broadened its remit, allowing more cases to be considered.
The idea of the ADR is to provide an alternative form of resolution for the many concerns raised with the RCVS which do not meet the College's threshold for serious professional misconduct and are, therefore, not taken through its disciplinary process.
The trial, which was originally due to end in May 2015, aims to gather evidence needed to develop a permanent scheme.
As well as the time-frame being extended, the trial will now also be widened to include concerns raised about the treatment of horses and other equines - in addition to those raised about small animals.
The RCVS has also lowered the maximum financial award that can be recommended by the Ombudsman Services, a not-for-profit complaints resolution service which is administering the trial, to £3,000 for small animal cases. The maximum financial award that can be recommended by the Ombudsman Services in relation to equine cases remains at £10,000.
Nick Stace, RCVS Chief Executive, said: "The trial got off to a slower start than we expected and so we have decided to extend its length and breadth to allow more time and scope to gather the evidence and testimonies which we need to assess the trial.
"It's important to stress again that the trial is free, voluntary, as both parties must agree to take part, and that the recommendations made by the Ombudsman Services are not binding - it is up to either party as to whether they accept them."
The results of the trial will now be reported to the November 2015 meeting of RCVS Council. For further information about the ADR trial please visit www.rcvs.org.uk/adr
Pfizer, manufacturer of the wormer StrongidTM-P has launched a new promotional campaign. Love your horse is based on simple, straightforward and unbiased educational messages to help ensure the optimum health and wellbeing of horses and ponies in the UK.
Pfizer's veterinary adviser Ben Gaskell said: "Simplistically, the three key tools for the horse owner to understand are diagnostics, worming and pasture management. If these tools are used in combination with specialist advice, then the horse owner will be able to provide a sustainable, reliable and cost-effective worm control strategy for their horse."
At the core of the campaign is a new range of four highly informative and uncomplicated leaflets directed at every type of horse owner: Do you need to worm; Choosing and using the right wormer; Managing your pasture and Worming and Your new horse.
"Each leaflet has been designed to work as a stand-alone piece or can be presented as a smart, matching series of four," says Helen Shirley, brand manager for StrongidTM-P. "The leaflets can be displayed in-store in a distinctive counter-top leaflet dispenser and are supported by eye-catching point of sale materials including posters and balloons."
The new campaign packs will be rolled out to all stockists from early June, supported by a dramatic new Love your horse advertisement in national equestrian trade and consumer titles.
The campaign will build up momentum over the summer months and into autumn's double dosing time with a series of authoritative, no-nonsense features and news stories from StrongidTM-P's veterinary advisor Ben Gaskell.
For further information please email: Strongid-P@pfizer.com
A Pet Obesity Task Force, the first of its kind in the country, has been launched at the European Pet Obesity Conference, hosted by Hill's Pet Nutrition to help tackle the growing number of obese and overweight pets and put in place strategies to help overcome the condition. The Task Force hopes to raise awareness of the growing health implications of obese and overweight pets, such as diabetes and osteoarthritis. The fact that pets are obese or overweight is often overlooked by owners and the group also aims to encourage them to identify weight problems and seek appropriate advice from vets. Mark Evans, chief veterinary adviser at the RSPCA, who will be sitting on the board, comments: "We've been trying to treat and prevent pet obesity for 20 years, but the problem hasn't gone away. In fact it seems to have got worse despite everyone's efforts. It's incredibly frustrating. So, is there any point in fighting on in the same old way if we're not winning the battle? "Let's take a step back, review our knowledge, re-evaluate our approaches, think outside the box and innovate. What could we learn from social scientists, human psychologists and others engaged in trying to tackle the very same problem in people - especially children?" Members of the Pet Obesity Task Force include: Mark Evans, chief veterinary adviser, RSPCA BVetMed MRCVS Professor John Innes BVSc PhD CertVR DSAS(Orth) MRCVS Professor Danielle Gunn-Moore BSc BVM&S PhD MACVSc MRCVS Daniel Chan DVM DipACVECC DipACVN MRCVS Nicola Ackerman BSc(Hons) RVN Cert SAN MBVNA Rachel Casey BVMS Dip(AS)CABC MRCVS Dr Ian Campbell GP Mike Jessop BVetMed MRCVS Dr Jacques Debraekeleer DVM, DipECVCN Simon Wheeler Head of marketing at Petplan
CEVA Animal Health is rolling out what it describes as a hard-hitting TV campaign on four national TV channels to highlight awareness of stress related feline behaviour problems and encourage cat owners to talk to their vet about Feliway.
This second bout of TV advertising will run in March and April on ITV2, ITV3, E4 and More 4 and on Channel 4 in the London region and will be seen by over five million people.
Featuring the animated character 'That Purple Cat' who first appeared in CEVA's TV advertising and marketing push at the end of 2009, the new campaign will see 'That Purple Cat' displaying signs of stress in the home environment to raise awareness of the issue amongst cat owners.
Lucy Brett, product manager at CEVA Animal Health said: "Our first TV advertising campaign back in the autumn went a long way to raise awareness. We found that more cat owners were able to recall the advertising for Feliway than for any other animal health brand.
"However, it is clear that in practice merchandising is crucial if practices are to make the most of this opportunity and I would encourage them to get in touch to request a display pack, which includes a waiting room poster and leaflets, as soon as possible."
A limited number of desktop and floor standing merchandising units are also available. For more information or to order your FREE waiting room merchandising materials call 01494 781510.
Ms Hazelwood faced three charges:
Having accepted her admissions on the charges, the Committee considered whether the three charges amounted to serious professional misconduct.
Regarding misconduct, Ms Hazelwood had also written to the RCVS prior to the start of the hearing and had accepted her conduct fell far short of what was expected of a veterinary nurse.
The Committee itself considered that Ms Hazelwood stealing the medication and other products was a serious breach of the trust placed in her by her employer, which had entrusted her with access to veterinary medications and their responsible use.
The Committee also considered that her conduct undermined the reputation of the profession and the public’s confidence in those within it. Accordingly, the Committee found that the charges amounted to serious professional conduct.
In terms of aggravating factors, the Committee considered that her conduct was a breach of trust and abuse of her professional position, that there was a possible risk to animal health in terms of the prescription-only veterinary medicine, that the conduct involved financial gain (albeit limited), that the conduct was sustained and repeated over a period of time, and that elements of her conduct were premeditated and sophisticated.
In terms of mitigation, the Committee noted that Ms Hazelwood had no previous disciplinary history and a hitherto unblemished career, that she had made open and frank admissions on her conduct and demonstrated genuine remorse, that there was no actual harm to animals, and that she demonstrated significant insight into her actions and the impact they could have on her colleagues and the wider profession, as well as taking into account a number of positive testimonials.
Judith Way, chairing the Committee and speaking on its behalf, said: “The Committee noted the mitigating factors in this case and that Ms Hazelwood stole these items at a time when she was under particular financial and personal pressure.
"She said it was out of character and her testimonials supported this assertion."
"The amounts involved were small and had been repaid.
“Furthermore, it was apparent that at the time Ms Hazelwood was struggling financially and her motivation was not so much financial gain but rather the need to feed and protect her animals.
"It was unfortunate that Ms Hazelwood had not attended this hearing, but in her written submissions she had, in the Committee’s view, demonstrated significant insight.
"Her writing came from the heart, she clearly recognised what a dreadful thing she had done and provided genuine expressions of apology and remorse.
“The Panel noted that Ms Hazelwood had worked as a veterinary nurse for some 16 years without incident.
"Her testimonials describe her as a very experienced and competent nurse, with an excellent work ethic and a real passion for the animals in her care.”
She added: “The Committee considered a period of suspension to mark the behaviour was both appropriate and proportionate in all the circumstances.
The order will be for a period of three months to reflect the seriousness of Ms Hazelwood’s disgraceful conduct, whilst reflecting the significant mitigation.
In light of the insight she has shown, the Committee was satisfied that it was highly unlikely Ms Hazelwood would ever behave in this way again and that she would be fit to return to practice after the period of suspension.
The Committee considered it would be wrong to deprive the profession of an otherwise competent veterinary nurse and that a member of the public in full possession of all the facts would not have their confidence in the profession undermined by such a decision.”
The full details of the case and the Committee’s decision can be found at www.rcvs.org.uk/disciplinary
Royal Canin has announced it is to launch Catom, a piece of software developed to help educate cat owners during veterinary consultations, at this year's London Vet Show.
Initially, the software will be available for PC and Mac, with iPad and Android versions coming by the end of the year.
You can can find out more by visiting Royal Canin's stand at the London Vet Show, where the company says it will have a large touch-screen TV displaying the software, along with laptop demos running throughout the exhibition.
The supermarket Morrisons is to launch new pet food packaging which will alert shoppers to the ideal portion size their cat or dog should be eating, in a bid to tackle the UK's growing pet obesity problem.
Morrisons is the first supermarket to add portion control guidance to the front of their pet food packaging, and it follows research from Petplan which found that 36% of all dogs and 29% of cats treated by vets are obese. In addition, 71% of vets agree that cases of obesity are continuing to rise.
Each packet of Morrisons pet food will provide the correct portion for a healthy weight pet and, according to the company, the packaging will communicate the amount of servings each product provides clearly.
Apparently, 70% of owners believe that their dog or cat has never been overweight, which shows that there is a level of confusion amongst owners as to how much their pet is eating. A further 83% do not even worry about giving their pet too much food. Morrisons is aiming to make it easier for pet lovers to ensure their animal doesn't put on any unnecessary weight especially with Christmas just around the corner and the temptation of being fed leftovers and treats.
According to vets asked by Petplan there are five main reasons for an obesity problem amongst household pets. They are:
John Cannan, New Product Development Manager for Pet Food at Morrisons said: "We've had feedback from our customers which says that they are often in the dark about how much food they should be buying and giving their pet. Our new packaging will ensure that shoppers have a clearer sense of portion sizes whilst also saving them some pennies"
Brian Faulkner Petplan Vet of the Year said: "It's great to see Morrisons taking the lead on this and helping shoppers make more informed decisions about what they are feeding their pet. Whilst it's normal to give your animal a treat every now and then, pets do need to follow healthy regimes just like we do. Keeping your pet fit and healthy will ultimately save you money on veterinary bills as well."
Vethelpdirect.com, the website founded by VetSurgeon.org member, Susie Samuel MRCVS, has launched a new system called VetReviews which allows your clients publish a review of your service directly from your own website.
To use the system, you (or perhaps more likely your website person) embed a small form on your website, called a widget, as shown on this example: www.baytreevets.co.uk (bottom right hand side).
Clients then click the link in the widget to submit a review of your practice, or to read existing reviews.
To ensure fair play, each review is checked by a person who removes any spammy or malicious reviews, and looks for any signs of fraudulent multiple reviews being submitted by one person.
In the event of a negative review, the practice is given 5 days to respond before the review is published, which means the review isn't displayed without the practice's side of the story.
However, as Susie points out, a single negative review is not necessarily a bad thing; most people are able to put one bad review into context. Indeed, a small number of negative, or less positive reviews tends to make the glowing ones seem more credible.
VetReviews are optimised for inclusion in Google search results, which should also help your search engine visibility.
For more information about VetReviews (which is a free upgrade for existing customers), email: vets@vethelpdirect.com, or telephone 0845 4961 204.
Intervet/Schering-Plough Animal Health has announced that it is re-introducing Equilis StrepE, the only strangles vaccine for horses in Europe. The vaccine was voluntarily withdrawn from the market in 2007 for stability reasons.
Equilis StrepE, which has already been relaunched in the Netherlands, is now scheduled to arrive in Italy in September and the United Kingdom in October this year. Further re-launches in European countries are scheduled later in 2010 and beyond.
According to Intervet/Schering-Plough, three years of additional research and development have resulted in several improvements to the vaccine, including a better manufacturing process to ensure that the product maintains its characteristics throughout its shelf-life. A more user-friendly applicator has been developed, which enables the needle to slot into place, thereby making it easier to administer the vaccine.
Equilis StrepE is administered through a submucosal injection in the upper lip of the horse and provides immunity for three months following two initial injections, four weeks apart. The vaccine significantly reduces clinical signs of strangles and occurrence of lymph node abscesses in horses that are at risk of infection.
Dr. Peter Daels, veterinarian at the Keros Insemination and Embryo Transfer Center in Beselare (Belgium) said: "In our recipient embryo transfer herd, we have used this strangles vaccine on over 500 mares. After a few applications, the vaccine was easy to administer and did not cause any serious side effects. Despite a steady flow of new horses, only eight cases of strangles were noted - all were mild and most were newly acquired horses that had apparently been exposed shortly before vaccination. I believe that the vaccine provided solid protection against the disease, reduced the severity of clinical cases and eliminated the risk of a widespread outbreak in our herd."
Dr. Roberto Ragni-Alunni, Global Technical Manager Equine at Intervet/Schering Plough Animal Health said: "The re-launch of Equilis StrepE in Europe is an important milestone in our efforts to fully meet the needs of our customers in the equine industry. We continue to work in a very intense and comprehensive way to ensure adequate supply of our equine vaccine range".